ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Friday, 13 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Asarfi Hospital Investor Presentation: Key Takeaways

Record Q2 FY27 consolidated: revenue ₹53.0 Cr (+18.1% YoY), EBITDA ₹11.9 Cr (22.4% margin), PAT ₹6.1 Cr (+45.2% YoY). Growth from outreach, insurance tie-ups and specialty mix.

Highlights
Revenue growth+18.1% YoY consolidated; ₹53.0 Cr
MarginsEBITDA margin 22.4% vs 19.8%; highest ever
Demand visibilityPatient volume +11% QoQ; surgeries +25% YoY

Growth

Consolidated revenue +18.1% YoY to ₹53.0 Cr; EBITDA +34.0%; PAT +45.2%. IPD +17%, OPD +39% YoY.

Outlook

No explicit numerical guidance given. Planning BSE SME to Main Board migration, subject to regulatory approvals.

Risks

Cancer unit revenue ₹11.6 Cr vs ₹11.9 Cr; surgical oncology -56%, radiation oncology -18%; cancer occupancy 40%.

Source

Investor Presentation filed with BSE, BSE: 543943. Summary written with AI assistance from the document.

Read the document ↗

Asarfi Hospital Ltd: key numbers

Share price
₹182.00
Market cap
₹358.1 Cr
Revenue (annual)
₹173.5 Cr
Net profit (annual)
₹16.66 Cr
P/E (TTM)
21.5×Sector 36.2×
Promoter holding
61.18%+0.01% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Asarfi Hospital Ltd

All →
17:44 IST BSE
Financial Results

Asarfi Hospital Q2 FY27 Results: Net Profit ₹6.1 Cr, Up 45.2% YoY

Asarfi Hospital Ltd reported revenue from operations of ₹53 Cr (+18.0% YoY) and net profit of ₹6.1 Cr (+45.2% YoY) for Q2 FY27.

Key figure
Net profit ₹6.1 Cr · +45.2% YoY